Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Regulation of Neuroinflammation through Programed Death-1/Programed Death Ligand Signaling in Neurological Disorders.
Multiple sclerosis: An old drug plays a new trick.
Phase 2 results of the RADIANCE trial: a randomized, double-blind, placebo-controlled trial of oral RPC1063 in relapsing multiple sclerosis
Ocular Findings in Alemtuzumab (Campath-1H)-induced Thyroid Eye Disease.
[Immunodepressive therapy in neurology].
A Multidimensional Computerized Adaptive Short-Form Quality of Life Questionnaire Developed and Validated for Multiple Sclerosis: The MusiQoL-MCAT.
Drug record: Amiloride
Agreement between physician's recommendation and fitness-to-drive decision in multiple sclerosis.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
Minocycline chelates Ca2+, binds to membranes, and depolarizes mitochondria by formation of Ca2+-dependent ion channels.
Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells.
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.
Acute relapse after initiation of Siponimod in a patient with secondary progressive MS.
Prospective Examination of Anxiety and Depression Before and During Confirmed and Pseudoexacerbations in Patients With Multiple Sclerosis.
Cystoid macular edema associated with fingolimod use for multiple sclerosis.
Autoimmunity: Rubbing salt in the wound.
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions.
Pathogenesis of multiple sclerosis via environmental and genetic dysregulation of N-glycosylation.
Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis.
Individual variation of human sphingosine 1-phosphate receptor 1 coding sequence leads to heterogeneity in receptor function and drug interactions.
Minocin
An Adult Case of Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Multiphasic Acute Disseminated Encephalomyelitis at 33-year Intervals.
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.
Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
Chaperone activity of α B-crystallin is responsible for its incorrect assignment as an autoantigen in multiple sclerosis.
Pages
« first
‹ previous
…
129
130
131
132
133
134
135
136
137
…
next ›
last »